These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures. Cesareo R, Iozzino M, Alva D, Napolitano C, De Rosa B, Contini S, Mallardo L, Lauria A, Reda G, Orsini A. Minerva Endocrinol; 2007 Dec; 32(4):275-95. PubMed ID: 18091664 [Abstract] [Full Text] [Related]
4. Preventing osteoporosis-related fractures: an overview. Gass M, Dawson-Hughes B. Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939 [Abstract] [Full Text] [Related]
5. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Bilezikian JP. Am J Med; 2009 Feb; 122(2 Suppl):S14-21. PubMed ID: 19187808 [Abstract] [Full Text] [Related]
6. [Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach]. Lamy O, Krieg MA. Praxis (Bern 1994); 2004 Mar 10; 93(11):399-405. PubMed ID: 15061107 [Abstract] [Full Text] [Related]
7. An approach to postmenopausal osteoporosis treatment: a case study review. Kessenich C. J Am Acad Nurse Pract; 2003 Dec 10; 15(12):539-45. PubMed ID: 14983569 [Abstract] [Full Text] [Related]
8. [Therapeutic strategies for osteoporosis]. Chapurlat R, Delmas PD. Ann Med Interne (Paris); 2000 Oct 10; 151(6):471-6. PubMed ID: 11104926 [Abstract] [Full Text] [Related]
9. [Large clinical trials for osteoporosis]. Meunier PJ. Therapie; 2003 Oct 10; 58(5):415-20. PubMed ID: 14682189 [Abstract] [Full Text] [Related]
10. Fracture prevention in postmenopausal women. Bruyere O, Edwards J, Reginster JY. Clin Evid; 2003 Dec 10; (10):1304-22. PubMed ID: 15555148 [No Abstract] [Full Text] [Related]
11. [Prevention and treatment of osteoporosis]. Galus K. Pol Arch Med Wewn; 2005 Dec 10; 114(6):1236-43. PubMed ID: 16789495 [No Abstract] [Full Text] [Related]
12. [New guideline for the treatment of osteoporosis]. Matsumoto T. Nihon Rinsho; 2004 Feb 10; 62 Suppl 2():387-91. PubMed ID: 15035157 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J, Takeda T, Sato Y. Curr Med Res Opin; 2006 May 10; 22(5):919-28. PubMed ID: 16709313 [Abstract] [Full Text] [Related]
14. Fracture prevention in postmenopausal women. Bruyere O, Edwards J, Reginster JY. Clin Evid; 2005 Jun 10; (13):1419-34. PubMed ID: 16135297 [No Abstract] [Full Text] [Related]
16. Drugs for prevention and treatment of postmenopausal osteoporosis. Treat Guidel Med Lett; 2002 Nov 10; 1(3):13-8. PubMed ID: 15529101 [No Abstract] [Full Text] [Related]
17. Review of treatment modalities for postmenopausal osteoporosis. Hamdy RC, Chesnut CH, Gass ML, Holick MF, Leib ES, Lewiecki ME, Maricic M, Watts NB. South Med J; 2005 Oct 10; 98(10):1000-14; quiz 1015-7, 1048. PubMed ID: 16295815 [Abstract] [Full Text] [Related]
19. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, Almasri J, Farah W, Sarigianni M, Muthusamy K, Al Nofal A, Haydour Q, Wang Z, Murad MH. J Clin Endocrinol Metab; 2019 May 01; 104(5):1623-1630. PubMed ID: 30907957 [Abstract] [Full Text] [Related]
20. Fracture prevention in postmenopausal women. Bruyere O, Edwards J, Reginster JY. Clin Evid; 2003 Jun 01; (9):1186-202. PubMed ID: 12967416 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]